JP6892079B2 - 制御性ｔ細胞誘導剤、アジュバント及び食品組成物 - Google Patents

制御性ｔ細胞誘導剤、アジュバント及び食品組成物 Download PDF

Info

Publication number
JP6892079B2
JP6892079B2 JP2018122078A JP2018122078A JP6892079B2 JP 6892079 B2 JP6892079 B2 JP 6892079B2 JP 2018122078 A JP2018122078 A JP 2018122078A JP 2018122078 A JP2018122078 A JP 2018122078A JP 6892079 B2 JP6892079 B2 JP 6892079B2
Authority
JP
Japan
Prior art keywords
lycopene
regulatory
food
food composition
allergen immunotherapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018122078A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019011314A5 (enExample
JP2019011314A (ja
Inventor
裕二 内藤
裕二 内藤
智久 ▲高▼木
智久 ▲高▼木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KYOTO PREFECTURAL UNIVERSITY OF MEDICINE
Kagome Co Ltd
Original Assignee
KYOTO PREFECTURAL UNIVERSITY OF MEDICINE
Kagome Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KYOTO PREFECTURAL UNIVERSITY OF MEDICINE, Kagome Co Ltd filed Critical KYOTO PREFECTURAL UNIVERSITY OF MEDICINE
Publication of JP2019011314A publication Critical patent/JP2019011314A/ja
Publication of JP2019011314A5 publication Critical patent/JP2019011314A5/ja
Application granted granted Critical
Publication of JP6892079B2 publication Critical patent/JP6892079B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2018122078A 2017-06-29 2018-06-27 制御性ｔ細胞誘導剤、アジュバント及び食品組成物 Active JP6892079B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017127846 2017-06-29
JP2017127846 2017-06-29

Publications (3)

Publication Number Publication Date
JP2019011314A JP2019011314A (ja) 2019-01-24
JP2019011314A5 JP2019011314A5 (enExample) 2019-09-26
JP6892079B2 true JP6892079B2 (ja) 2021-06-18

Family

ID=65227877

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018122078A Active JP6892079B2 (ja) 2017-06-29 2018-06-27 制御性ｔ細胞誘導剤、アジュバント及び食品組成物

Country Status (1)

Country Link
JP (1) JP6892079B2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021143142A (ja) * 2020-03-11 2021-09-24 花王株式会社 制御性ｔ細胞誘導剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4328514B2 (ja) * 2002-11-11 2009-09-09 カゴメ株式会社 抗アレルギー剤
SG11201607674SA (en) * 2014-03-14 2016-11-29 Meiji Co Ltd Retinoic-acid-producing agent
AU2016290513B2 (en) * 2015-07-03 2022-08-11 Centre Hospitalier Universitaire De Nantes Methods for obtaining regulatory T cells and uses thereof
EA201890856A1 (ru) * 2015-09-30 2018-10-31 Бёрингер Ингельхайм Ветмедика Гмбх Улучшенные транспортные молекулы модулярного антигена и их применение у животных
JP2017081891A (ja) * 2015-10-27 2017-05-18 株式会社ホソダＳｈｃ 制御性ｔ細胞活性組成物

Also Published As

Publication number Publication date
JP2019011314A (ja) 2019-01-24

Similar Documents

Publication Publication Date Title
US10555975B2 (en) Prevotella histicola preparations and the treatment of autoimmune conditions
Von Geldern et al. The influence of nutritional factors on the prognosis of multiple sclerosis
TWI424840B (zh) β-羥基-β-甲基丁酸酯之用途
US20110009360A1 (en) Nutraceutical Composition and Methods for Preventing or Treating Multiple Sclerosis
AU2012209285B2 (en) Methods and compositions for treating, reducing or preventing deterioration of the visual system of animals
KR101778734B1 (ko) 비피도박테리움 롱검 kacc 91563으로부터 분리된 esbp 및 이를 이용한 항알레르기 조성물
US20240058396A1 (en) NOVEL STRAIN OF Bifidobacterium animalis subsp. lactis HEM20-01 AND COMPOSITION FOR treating depression, COMPRISING the same OR its culture fluid
JP7705633B2 (ja) 内臓脂肪低減剤
US20140030807A1 (en) Method for stimulating foxp3+ regulatory t cell expression of cd39
US20050165105A1 (en) Method of using punicic acid to enhance immune response and prevent metabolic disorders
JP6892079B2 (ja) 制御性ｔ細胞誘導剤、アジュバント及び食品組成物
JP2014166972A (ja) 腸炎抑制剤及び飲食品
US8580278B2 (en) Nutraceutical composition and methods for preventing or treating multiple sclerosis
JP2020531587A (ja) 組成物およびそれから作られた栄養サプリメント
WO2017191838A1 (ja) 安全・安定なプラズマローゲンとその製剤及び認知症の未病状態の判定方法
JP7492222B2 (ja) アディポネクチン受容体作動薬及びその使用、並びにアディポネクチン受容体作動用食品組成物及びその使用
WO2005070412A2 (en) Method of using punicic acid to enhance immune response and prevent metabolic disorders
JP2012254959A (ja) Ｉｌ−１７産生抑制剤
JP7206623B2 (ja) 糖代謝異常の予防および改善用組成物
CN106659707B (zh) 红细胞功能提高剂
Azzahra et al. Wisdom of nature: Cardiovascular, anti-obesity, and immunomodulator nutraceuticals
JP7242219B2 (ja) 血糖値上昇抑制剤、糖尿病抑制剤、及び食品組成物
Kartikey et al. Effects of oxidative stress on development of osteoporosis, carcinogenesis, atherosclerosis and brain degeneration
JP2024121661A (ja) 血糖改善剤
Percival et al. Workshop executive summary report

Legal Events

Date Code Title Description
AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20180717

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180712

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190809

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190809

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200623

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201117

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201222

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210420

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210518

R150 Certificate of patent or registration of utility model

Ref document number: 6892079

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250